1 Department of Medicine, University of Toronto, Toronto, Ontario, Canada; and.
2 Department of Medicine.
Am J Respir Crit Care Med. 2016 Jul 15;194(2):218-25. doi: 10.1164/rccm.201512-2393OC.
Patients commonly use the Internet as a resource for health information; however, no studies have evaluated the online information about idiopathic pulmonary fibrosis (IPF).
We sought to determine the readability, content (compared with established guidelines), bias, and quality of online IPF resources.
We analyzed the first 200 hits for "idiopathic pulmonary fibrosis" in Google, Yahoo, and Bing. Each website was evaluated for content related to IPF features and treatments that are discussed in clinical guidelines. Website quality was assessed using the validated DISCERN instrument.
Eligibility criteria were met in 181 websites. The median reading grade level was 12. More content was provided in scientific resources (academic institutions or governmental organizations) and foundation/advocacy organization sites than in personal commentary (blog) sites; however, most sites provided incomplete and/or inaccurate information. Nonindicated and/or harmful pharmacotherapies for IPF were described as potential IPF treatments in 48% of websites and were most often recommended in foundation/advocacy organization websites. Azathioprine and corticosteroids were discussed as potential chronic treatments of IPF in 13.3 and 30.6% of the 98 websites that had been updated after publication of data demonstrating harm from these medications. Website quality (DISCERN score) was poor in all site types but was worse in news/media reports and personal commentary (blog) sites than in sites from scientific and foundation/advocacy organizations.
Patient-directed online information on IPF is frequently incomplete, inaccurate, and outdated. There is no reliable method for patients to identify sites that provide appropriate information on IPF.
患者通常将互联网作为获取健康信息的资源;然而,目前尚无研究评估过关于特发性肺纤维化(IPF)的在线信息。
我们旨在确定在线 IPF 资源的易读性、内容(与既定指南相比)、偏差和质量。
我们分析了 Google、Yahoo 和 Bing 中“特发性肺纤维化”的前 200 个搜索结果。根据临床指南中讨论的 IPF 特征和治疗方法,评估每个网站的内容相关性。使用经过验证的 DISCERN 工具评估网站质量。
符合纳入标准的网站有 181 个。中位数阅读水平为 12 级。学术机构或政府组织以及基金会/宣传组织网站提供的内容多于个人评论(博客)网站,但大多数网站提供的信息不完整和/或不准确。48%的网站将未经指示和/或有害的 IPF 药物治疗描述为潜在的 IPF 治疗方法,这些方法最常被推荐在基金会/宣传组织网站中。在 98 个更新后发布的数据表明这些药物有危害的网站中,有 13.3%和 30.6%讨论了硫唑嘌呤和皮质类固醇作为 IPF 的潜在慢性治疗方法。所有网站类型的网站质量(DISCERN 评分)均较差,但新闻/媒体报道和个人评论(博客)网站比来自科学和基金会/宣传组织的网站更差。
面向患者的 IPF 在线信息经常不完整、不准确且过时。患者无法确定提供 IPF 适当信息的可靠方法。